View Study [3]"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity" Garvey WT et al., 2025 Finding: The REDEFINE 1 Phase 3 trial showed CagriSema achieved 20.4% weight loss versus 3% with placebo over 68 weeks in 3,417 participants
Always use a new needle for each injection
Earlier mechanistic studies focused on its protonophore activity in pure lipid bilayers, but growing evidence now points to a more complex interaction involving mitochondrial proteins, such as UCPs, ANT1, and OGC
Botanical Extracts The formula also includes various botanical extracts like broccoli, grapefruit, chamomile, lavender, peppermint, sage, and rosemary